Skip to main content

Want a detailed portfolio tracker?

Verona Pharma (VRNA) P/E (2020 - 2025)

Verona Pharma (VRNA) P/E from Mar 31, 2020 to Oct 7, 2025. The TTM Verona Pharma (VRNA) P/E is -852.64. You can export chart.

P/E

Annual P/E change of Verona Pharma (VRNA)

YearP/EChange
2025-852.64+390.15%
2024-173.95-26.86%
2023-237.83+51.19%
2022-157.30+180.81%
2021-56.02+281.89%
2020-14.67N/A

Comparison Verona Pharma (VRNA) P/E with competitors

Verona Pharma (VRNA) P/E is -852.64.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.01%
FGENFibroGen Inc0.24-100.03%
CHRSCoherus Biosciences Inc0.85-100.10%
FBIOFortress Biotech Inc0.95-100.11%
ORMPOramed Pharmaceuticals Inc1.50-100.18%
AGENAgenus Inc3.01-100.35%
INVAInnoviva Inc3.15-100.37%
VXRTVaxart Inc3.55-100.42%
CRMDCorMedix Inc3.63-100.43%
CVACCureVac N.V.4.45-100.52%
GLPGGalapagos NV4.86-100.57%
SRPTSarepta Therapeutics Inc4.88-100.57%
ABEOAbeona Therapeutics Inc5.39-100.63%
ABUSArbutus Biopharma Corp5.60-100.66%
ZVRAZevra Therapeutics Inc5.89-100.69%
SPROSpero Therapeutics Inc6.23-100.73%
CGENCompugen Ltd6.31-100.74%
RIGLRigel Pharmaceuticals6.87-100.81%
SLXNSilexion Therapeutics Corp7.30-100.86%
OMEROmeros Corporation9.26-101.09%
AUPHAurinia Pharmaceuticals Inc9.58-101.12%
PLXProtalix BioTherapeutics Inc10.89-101.28%
ACADAcadia Pharmaceuticals Inc11.73-101.38%
TBPHTheravance Biopharma Inc12.26-101.44%
ADMAAdma Biologics Inc12.42-101.46%
HRMYHarmony Biosciences Holdings Inc13.82-101.62%
SABSSAB Biotherapeutics Inc14.14-101.66%
NAGENiagen Bioscience Inc14.82-101.74%
INCYIncyte Corp15.82-101.86%
REGNRegeneron Pharmaceuticals Inc15.86-101.86%
PBYIPuma Biotechnology Inc17.32-102.03%
CPRXCatalyst Pharmaceuticals Inc17.44-102.05%
EXELExelixis Inc17.54-102.06%
TGTXTG Therapeutics Inc18.97-102.22%
MDXGMimedx Group Inc20.55-102.41%
XOMAXOMA Royalty Corp22.87-102.68%
ARGXArgen X SE24.30-102.85%
CTMXCytomX Therapeutics Inc24.82-102.91%
XOMAOXOMA Royalty Corp25.34-102.97%
HALOHalozyme Therapeutics Inc25.62-103.01%
XOMAPXOMA Royalty Corp25.67-103.01%
VRTXVertex Pharmaceuticals Inc27.99-103.28%
RPRXRoyalty Pharma plc - Class A28.69-103.36%
SLNOSoleno Therapeutics Inc29.02-103.40%
ASNDAscendis Pharma A/S30.09-103.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-104.45%
APLSApellis Pharmaceuticals Inc39.02-104.58%
BMRNBiomarin Pharmaceutical Inc42.21-104.95%
KRYSKrystal Biotech Inc45.34-105.32%
ONCBeiGene Ltd69.54-108.16%
PHARPharming Group N.V.75.03-108.80%
TECHBio-Techne Corp101.96-111.96%
VCELVericel Corp109.92-112.89%
ALNYAlnylam Pharmaceuticals Inc117.96-113.84%
GMABGenmab140.29-116.45%
TLXTelix Pharmaceuticals Ltd162.15-119.02%
CORTCorcept Therapeutics Inc212.86-124.96%